HEADER SIGNALING PROTEIN 06-OCT-20 7KCO
TITLE ROR GAMMA IN COMPLEX WITH SCR2 AND COMPOUND 3
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1
COMPND 5 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED
COMPND 6 ORPHAN RECEPTOR-GAMMA;
COMPND 7 ENGINEERED: YES;
COMPND 8 MOL_ID: 2;
COMPND 9 MOLECULE: PEPTIDE GLU-LYS-HIS-LYS-ILE-LEU-HIS-ARG-LEU-LEU-GLN-ASP-
COMPND 10 SER;
COMPND 11 CHAIN: C, D;
COMPND 12 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 MOL_ID: 2;
SOURCE 9 SYNTHETIC: YES;
SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 11 ORGANISM_TAXID: 9606
KEYWDS INHIBITOR, SIGNALING PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR J.D.DURBIN,S.Y.GUO,S.L.STOUT,D.K.CLAWSON
REVDAT 4 03-APR-24 7KCO 1 REMARK
REVDAT 3 06-MAR-24 7KCO 1 REMARK
REVDAT 2 26-MAY-21 7KCO 1 JRNL
REVDAT 1 21-APR-21 7KCO 0
JRNL AUTH C.W.LUGAR,C.A.CLARKE,R.MORPHY,H.RUDYK,S.SAPMAZ,R.E.STITES,
JRNL AUTH 2 G.M.VAUGHT,K.FURNESS,H.B.BROUGHTON,G.L.DURST,D.K.CLAWSON,
JRNL AUTH 3 S.L.STOUT,S.Y.GUO,J.D.DURBIN,K.R.STAYROOK,D.D.EDMONDSON,
JRNL AUTH 4 K.KIKLY,N.E.NEW,H.A.BINA,M.G.CHAMBERS,P.SHETLER,W.Y.CHANG,
JRNL AUTH 5 V.C.CHANG,R.BARR,W.H.GOUGH,J.P.STEELE,B.GETMAN,N.PATEL,
JRNL AUTH 6 B.M.MATHES,T.I.RICHARDSON
JRNL TITL DEFINING TARGET ENGAGEMENT REQUIRED FOR EFFICACY IN VIVO AT
JRNL TITL 2 THE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR C2 (ROR
JRNL TITL 3 GAMMA T).
JRNL REF J.MED.CHEM. V. 64 5470 2021
JRNL REFN ISSN 0022-2623
JRNL PMID 33852312
JRNL DOI 10.1021/ACS.JMEDCHEM.0C01918
REMARK 2
REMARK 2 RESOLUTION. 1.86 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.7 (19-MAR-2020)
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.98
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4
REMARK 3 NUMBER OF REFLECTIONS : 43923
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.191
REMARK 3 R VALUE (WORKING SET) : 0.190
REMARK 3 FREE R VALUE : 0.231
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.360
REMARK 3 FREE R VALUE TEST SET COUNT : 1038
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 51
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.87
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.65
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 879
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2228
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 860
REMARK 3 BIN R VALUE (WORKING SET) : 0.2205
REMARK 3 BIN FREE R VALUE : 0.3377
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.16
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 19
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4162
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 78
REMARK 3 SOLVENT ATOMS : 377
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 19.57
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.20
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -3.42320
REMARK 3 B22 (A**2) : 7.80610
REMARK 3 B33 (A**2) : -4.38290
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.260
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.162
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.144
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.152
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.141
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.888
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 4418 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 5989 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1568 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES : 786 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 4418 ; 10.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 554 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 4247 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.008
REMARK 3 BOND ANGLES (DEGREES) : 0.85
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.65
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.48
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 7KCO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-OCT-20.
REMARK 100 THE DEPOSITION ID IS D_1000252264.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 31-JAN-13
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 31-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97931
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.20
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44020
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860
REMARK 200 RESOLUTION RANGE LOW (A) : 91.557
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7
REMARK 200 DATA REDUNDANCY : 6.200
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.08200
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94
REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2
REMARK 200 DATA REDUNDANCY IN SHELL : 4.70
REMARK 200 R MERGE FOR SHELL (I) : 0.70100
REMARK 200 R SYM FOR SHELL (I) : 0.70100
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.100
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: IN HOUSE
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 42.57
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, AMMONIUM TARTRATE, VAPOR
REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 294K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.09650
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.77850
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.05700
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.77850
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.09650
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.05700
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5090 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 22290 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLU C 685
REMARK 465 LYS C 686
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ARG A 288 NE CZ NH1 NH2
REMARK 470 GLU A 290 CG CD OE1 OE2
REMARK 470 ARG A 294 CG CD NE CZ NH1 NH2
REMARK 470 ARG A 302 CG CD NE CZ NH1 NH2
REMARK 470 GLU A 303 CG CD OE1 OE2
REMARK 470 GLN A 346 CD OE1 NE2
REMARK 470 GLU A 395 CG CD OE1 OE2
REMARK 470 ARG A 437 CG CD NE CZ NH1 NH2
REMARK 470 GLU A 440 CG CD OE1 OE2
REMARK 470 LYS A 465 CD CE NZ
REMARK 470 LYS A 469 CG CD CE NZ
REMARK 470 LYS A 471 CE NZ
REMARK 470 GLN A 484 CG CD OE1 NE2
REMARK 470 GLN B 275 CD OE1 NE2
REMARK 470 ARG B 302 CG CD NE CZ NH1 NH2
REMARK 470 GLN B 346 CG CD OE1 NE2
REMARK 470 LYS B 503 CG CD CE NZ
REMARK 470 LYS C 688 CG CD CE NZ
REMARK 470 GLN C 695 CD OE1 NE2
REMARK 470 SER C 697 OG
REMARK 470 GLU D 685 CG CD OE1 OE2
REMARK 470 LYS D 686 CG CD CE NZ
REMARK 470 LYS D 688 CG CD CE NZ
REMARK 470 GLN D 695 CD OE1 NE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLN A 286 -64.90 75.59
REMARK 500 GLN B 286 -64.16 73.27
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH B 894 DISTANCE = 6.69 ANGSTROMS
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue WB7 A 601
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue WB7 B 601
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 602
DBREF 7KCO A 262 507 UNP P51449 RORG_HUMAN 262 507
DBREF 7KCO B 262 507 UNP P51449 RORG_HUMAN 262 507
DBREF 7KCO C 685 697 PDB 7KCO 7KCO 685 697
DBREF 7KCO D 685 697 PDB 7KCO 7KCO 685 697
SEQADV 7KCO SER A 260 UNP P51449 EXPRESSION TAG
SEQADV 7KCO LEU A 261 UNP P51449 EXPRESSION TAG
SEQADV 7KCO SER B 260 UNP P51449 EXPRESSION TAG
SEQADV 7KCO LEU B 261 UNP P51449 EXPRESSION TAG
SEQRES 1 A 248 SER LEU ALA PRO TYR ALA SER LEU THR GLU ILE GLU HIS
SEQRES 2 A 248 LEU VAL GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS
SEQRES 3 A 248 GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN
SEQRES 4 A 248 ILE PHE SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS
SEQRES 5 A 248 SER MET TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU
SEQRES 6 A 248 THR GLU ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG
SEQRES 7 A 248 LEU SER GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE
SEQRES 8 A 248 VAL LEU LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL
SEQRES 9 A 248 ARG MET CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL
SEQRES 10 A 248 PHE PHE GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG
SEQRES 11 A 248 ALA LEU GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP
SEQRES 12 A 248 PHE SER HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP
SEQRES 13 A 248 GLU ILE ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA
SEQRES 14 A 248 HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN
SEQRES 15 A 248 LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU
SEQRES 16 A 248 CYS LYS THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO
SEQRES 17 A 248 PRO LYS GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL
SEQRES 18 A 248 GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS PRO ILE VAL
SEQRES 19 A 248 VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS GLU LEU PHE
SEQRES 20 A 248 SER
SEQRES 1 B 248 SER LEU ALA PRO TYR ALA SER LEU THR GLU ILE GLU HIS
SEQRES 2 B 248 LEU VAL GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS
SEQRES 3 B 248 GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN
SEQRES 4 B 248 ILE PHE SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS
SEQRES 5 B 248 SER MET TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU
SEQRES 6 B 248 THR GLU ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG
SEQRES 7 B 248 LEU SER GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE
SEQRES 8 B 248 VAL LEU LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL
SEQRES 9 B 248 ARG MET CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL
SEQRES 10 B 248 PHE PHE GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG
SEQRES 11 B 248 ALA LEU GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP
SEQRES 12 B 248 PHE SER HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP
SEQRES 13 B 248 GLU ILE ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA
SEQRES 14 B 248 HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN
SEQRES 15 B 248 LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU
SEQRES 16 B 248 CYS LYS THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO
SEQRES 17 B 248 PRO LYS GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL
SEQRES 18 B 248 GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS PRO ILE VAL
SEQRES 19 B 248 VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS GLU LEU PHE
SEQRES 20 B 248 SER
SEQRES 1 C 13 GLU LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER
SEQRES 1 D 13 GLU LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER
HET WB7 A 601 36
HET WB7 B 601 36
HET GOL B 602 6
HETNAM WB7 1-[(2-CHLOROPHENYL)METHYL]-N-{[4-(METHYLSULFONYL)
HETNAM 2 WB7 PHENYL]METHYL}-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-
HETNAM 3 WB7 THIENO[2,3-C]PYRAN]-2'-CARBOXAMIDE
HETNAM GOL GLYCEROL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 5 WB7 2(C27 H29 CL N2 O4 S2)
FORMUL 7 GOL C3 H8 O3
FORMUL 8 HOH *377(H2 O)
HELIX 1 AA1 SER A 266 GLU A 283 1 18
HELIX 2 AA2 ARG A 288 GLN A 295 1 8
HELIX 3 AA3 SER A 301 LYS A 311 1 11
HELIX 4 AA4 SER A 312 LEU A 338 1 27
HELIX 5 AA5 GLY A 340 LEU A 344 5 5
HELIX 6 AA6 CYS A 345 MET A 365 1 21
HELIX 7 AA7 GLY A 384 GLY A 392 5 9
HELIX 8 AA8 CYS A 393 ALA A 409 1 17
HELIX 9 AA9 SER A 413 ILE A 426 1 14
HELIX 10 AB1 GLU A 435 THR A 457 1 23
HELIX 11 AB2 ARG A 459 LEU A 466 5 8
HELIX 12 AB3 GLY A 470 HIS A 490 1 21
HELIX 13 AB4 HIS A 490 PHE A 498 1 9
HELIX 14 AB5 PRO A 499 SER A 507 1 9
HELIX 15 AB6 SER B 266 GLU B 283 1 18
HELIX 16 AB7 ARG B 288 GLN B 295 1 8
HELIX 17 AB8 SER B 301 ARG B 310 1 10
HELIX 18 AB9 SER B 312 LEU B 338 1 27
HELIX 19 AC1 GLY B 340 LEU B 344 5 5
HELIX 20 AC2 CYS B 345 MET B 365 1 21
HELIX 21 AC3 GLY B 384 GLY B 392 5 9
HELIX 22 AC4 CYS B 393 ALA B 409 1 17
HELIX 23 AC5 SER B 413 ILE B 426 1 14
HELIX 24 AC6 GLU B 435 THR B 457 1 23
HELIX 25 AC7 ARG B 459 LEU B 466 5 8
HELIX 26 AC8 PRO B 468 HIS B 490 1 23
HELIX 27 AC9 HIS B 490 PHE B 498 1 9
HELIX 28 AD1 PRO B 499 SER B 507 1 9
HELIX 29 AD2 LYS C 688 ASP C 696 1 9
HELIX 30 AD3 HIS D 687 ASP D 696 1 10
SHEET 1 AA1 3 TYR A 369 ASN A 370 0
SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370
SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378
SHEET 1 AA2 3 TYR B 369 ASN B 370 0
SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370
SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378
SITE 1 AC1 14 CYS A 285 GLN A 286 LEU A 287 TRP A 317
SITE 2 AC1 14 HIS A 323 LEU A 324 ARG A 364 MET A 365
SITE 3 AC1 14 ARG A 367 ALA A 368 PHE A 377 CYS A 393
SITE 4 AC1 14 LEU A 396 HOH A 718
SITE 1 AC2 14 CYS B 285 GLN B 286 LEU B 287 TRP B 317
SITE 2 AC2 14 HIS B 323 ARG B 364 MET B 365 ARG B 367
SITE 3 AC2 14 ALA B 368 VAL B 376 PHE B 377 CYS B 393
SITE 4 AC2 14 LEU B 396 HOH B 765
SITE 1 AC3 6 CYS B 366 LEU B 407 HIS B 411 PHE B 412
SITE 2 AC3 6 HOH B 753 HOH B 842
CRYST1 66.193 86.114 91.557 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015107 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011613 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010922 0.00000